87 related articles for article (PubMed ID: 15342417)
1. Boron-containing nucleosides as potential delivery agents for neutron capture therapy of brain tumors.
Barth RF; Yang W; Al-Madhoun AS; Johnsamuel J; Byun Y; Chandra S; Smith DR; Tjarks W; Eriksson S
Cancer Res; 2004 Sep; 64(17):6287-95. PubMed ID: 15342417
[TBL] [Abstract][Full Text] [Related]
2. Rat brain tumor models to assess the efficacy of boron neutron capture therapy: a critical evaluation.
Barth RF; Yang W; Coderre JA
J Neurooncol; 2003; 62(1-2):61-74. PubMed ID: 12749703
[TBL] [Abstract][Full Text] [Related]
3. Translational research of boron neutron capture therapy for spinal cord gliomas using rat model.
Kayama R; Tsujino K; Kawabata S; Fujikawa Y; Kashiwagi H; Fukuo Y; Hiramatsu R; Takata T; Tanaka H; Suzuki M; Hu N; Miyatake SI; Takami T; Wanibuchi M
Sci Rep; 2024 Apr; 14(1):8265. PubMed ID: 38594281
[TBL] [Abstract][Full Text] [Related]
4. Ligand liposomes and boron neutron capture therapy.
Carlsson J; Kullberg EB; Capala J; Sjöberg S; Edwards K; Gedda L
J Neurooncol; 2003; 62(1-2):47-59. PubMed ID: 12749702
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid-based boron delivery system may help increase the uptake boron for boron neutron capture therapy in veterinary medicine: A preliminary study with normal rat brain cells.
Kusaka S; Morizane Y; Tokumaru Y; Tamaki S; Maemunah IR; Akiyama Y; Sato F; Murata I
Res Vet Sci; 2022 Nov; 148():1-6. PubMed ID: 35523003
[TBL] [Abstract][Full Text] [Related]
6. Targeted strategies to deliver boron agents across the blood-brain barrier for neutron capture therapy of brain tumors.
Lan G; Song Q; Luan Y; Cheng Y
Int J Pharm; 2024 Jan; 650():123747. PubMed ID: 38151104
[TBL] [Abstract][Full Text] [Related]
7. Fluorine-18 labeling PEGylated 6-boronotryptophan for PET scanning of mice for assessing the pharmacokinetics for boron neutron capture therapy of brain tumors.
Chen XP; Hsu FC; Huang KY; Hsieh TS; Farn SS; Sheu RJ; Yu CS
Bioorg Med Chem Lett; 2024 Jun; 105():129744. PubMed ID: 38614152
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vivo murine evaluation of Na4[1-(1'-B10H9)-6-SHB10H8] as a potential agent for boron neutron capture therapy.
Feakes DA; Waller RC; Hathaway DK; Morton VS
Proc Natl Acad Sci U S A; 1999 May; 96(11):6406-10. PubMed ID: 10339600
[TBL] [Abstract][Full Text] [Related]
9. Permeability of the blood-brain barrier to a rhenacarborane.
Hawkins PM; Jelliss PA; Nonaka N; Shi X; Banks WA
J Pharmacol Exp Ther; 2009 May; 329(2):608-14. PubMed ID: 19179541
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro properties of trimethylamine- and phosphonate-substituted carboranylporphyrins for application in BNCT.
Easson MW; Fronczek FR; Jensen TJ; Vicente MG
Bioorg Med Chem; 2008 Mar; 16(6):3191-208. PubMed ID: 18178445
[TBL] [Abstract][Full Text] [Related]
11. Lithium salts cytotoxicity and accumulation in melanoma cells in vitro.
Taskaeva I; Kasatova A; Razumov I; Bgatova N; Taskaev S
J Appl Toxicol; 2024 May; 44(5):712-719. PubMed ID: 38146629
[TBL] [Abstract][Full Text] [Related]
12. Macrophages as carriers of boron carbide nanoparticles dedicated to boron neutron capture therapy.
Wróblewska A; Szermer-Olearnik B; Szczygieł A; Węgierek-Ciura K; Mierzejewska J; Kozień D; Żeliszewska P; Kruszakin R; Migdał P; Pędzich Z; Pajtasz-Piasecka E
J Nanobiotechnology; 2024 Apr; 22(1):183. PubMed ID: 38622691
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Probiotic Properties and Whole-Genome Analysis of
Wang K; Wang Y; Gu L; Yu J; Liu Q; Zhang R; Liang G; Chen H; Gu F; Liu H; Jiao X; Zhang Y
Microorganisms; 2024 Mar; 12(4):. PubMed ID: 38674616
[TBL] [Abstract][Full Text] [Related]
14. Correction to: Proposal of recommended experimental protocols for in vitro and in vivo evaluation methods of boron agents for neutron capture therapy.
J Radiat Res; 2023 Nov; 64(6):983. PubMed ID: 37775502
[No Abstract] [Full Text] [Related]
15. Connecting calcium signaling with boron transport: the crucial role of CPK10 protein kinase.
Huang CF
New Phytol; 2024 May; ():. PubMed ID: 38703002
[No Abstract] [Full Text] [Related]
16. Association of thymidine kinase-1 with prostate cancer.
Jiang C; Zhou W; Wang L; Ke C
Asian J Surg; 2024 Feb; 47(2):1302-1303. PubMed ID: 38135534
[No Abstract] [Full Text] [Related]
17. In Vivo Application of Carboranes for Boron Neutron Capture Therapy (BNCT): Structure, Formulation and Analytical Methods for Detection.
Marforio TD; Carboni A; Calvaresi M
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894311
[TBL] [Abstract][Full Text] [Related]
18. Exploiting Blood Transport Proteins as Carborane Supramolecular Vehicles for Boron Neutron Capture Therapy.
Marforio TD; Mattioli EJ; Zerbetto F; Calvaresi M
Nanomaterials (Basel); 2023 May; 13(11):. PubMed ID: 37299673
[TBL] [Abstract][Full Text] [Related]
19. Boron Neutron Capture Therapy: Current Status and Challenges.
Wang S; Zhang Z; Miao L; Li Y
Front Oncol; 2022; 12():788770. PubMed ID: 35433432
[TBL] [Abstract][Full Text] [Related]
20. Boron-containing nucleosides as tools for boron-neutron capture therapy.
Zharkov DO; Yudkina AV; Riesebeck T; Loshchenova PS; Mostovich EA; Dianov GL
Am J Cancer Res; 2021; 11(10):4668-4682. PubMed ID: 34765286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
